Prot# ECOG PCO-RL: E3503: A Pilot Study to Determine if Downstream Markers of EGFR Linked Signaling Pathways Predict Response to OSR-774 (Erlotinib) in the First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/09 → 3/31/16

Funding

  • Frontier Science and Technology Research Foundation (PCOE3503-00 // PCOE3503-00)
  • OSI Pharmaceuticals, Inc. (PCOE3503-00 // PCOE3503-00)